Canary Speech and Microsoft Collaboration to Revolutionize Healthcare at HIMSS

Canary Speech, a pioneering company specializing in AI-driven vocal biomarker technology, recently announced its participation in the Microsoft Booth at the HIMSS conference in Las Vegas, running from March 3 to 6, 2025. This strategic collaboration aims to set new benchmarks in managing mental health and cognitive disorders through innovative technology.

This partnership was forged last year, allowing Canary Speech to leverage Microsoft Cloud for Healthcare, which helps them scale their operations across several key markets, including the United States, Japan, the United Kingdom, and South America. By integrating with Microsoft Azure Marketplace, healthcare organizations can conveniently access software subscriptions that enable effective patient monitoring for early disease detection and impairment.

In remarks made by Henry O'Connell, CEO and co-founder of Canary Speech, he highlighted the role of Microsoft in driving digital transformation in healthcare. He stated, "The opportunities provided by Microsoft are helping us transform our business to deliver impactful, human-centered solutions. AI-enabled vocal biomarkers, powered by Microsoft's ambient listening technology, are revolutionizing healthcare by providing objective, real-time insights that enhance clinical decision-making."

O'Connell emphasizes that the incorporation of voice as a new vital sign empowers clinicians with essential tools aimed at improving patient outcomes. Canary Speech’s proprietary technology employs advanced analysis using AI and machine learning techniques to capture and measure critical speech data effectively, complementing existing subjective behavioral health assessments.

As the partnership with Microsoft progresses, Canary Speech takes pride in being one of the first collaborators to integrate its technology with Microsoft Dragon Copilot's ambient listening platform. This integration promises added value to healthcare providers seeking innovative solutions.

Kenneth Harper, General Manager for Microsoft’s Dragon Product, commended the collaboration, referencing their commitment to transforming healthcare through powerful partnerships. He stated, "Our collaboration with Canary Speech exemplifies this commitment, and we look forward to the positive impact our work together will have on healthcare organizations, their providers, and the patients they serve."

Attendees of HIMSS are encouraged to visit the Microsoft Booth (#2221) on Level 2 of The Venetian Convention and Expo Center for more information on Canary Speech’s cutting-edge techniques and offerings. For those unable to visit in person, queries can be directed via email to [email protected]

About Canary Speech

Canary Speech is renowned for its AI-driven voice biomarker technology, which utilizes real-time vocal analysis to assess and identify mental health and neurological disorders. Their innovative technology captures speech data in seconds, allowing for early detection of issues related to anxiety, depression, and dementia, often before clinical standards recognize any irregularities. Based in Utah, Canary Speech is revolutionizing the integration of speech and language applications within health systems, payer networks, and the pharmaceutical market.